http://medicaljournalshouse.com/index.php/IntJ-PreventiveCardiology International Journal of Preventive Cardiology (IJoPC) is a peer-reviewed and an open access journal covering recent studies/ researches happening globally in preventive cardiology, playing a pivotal role in reducing the global burden of cardiovascular disease. IJoPC addresses the causes and prevention of cardiovascular disease, as well as cardiovascular rehabilitation and exercise physiology. IntJoARGO accept articles with scientific excellence in the form of (1) Original articles in basic and field research (2) Critical Reviews, (3) Surveys, (4) Case Studies, (5) Opinions/Correspondence/Letters to Editor (6) Clinical Image articles etc. Advanced Research Publications is in collaboration with Crossref and will be allotting DOI’s through the same for global recognition of the published content. en-US <p>We, the undersigned, give an undertaking to the following effect with regard to our article entitled<br>“_______________________________________________________________________________________________________________________________________________________________________________<br>________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-</p> <p>1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.</p> <p>2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.</p> <p>3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.</p> <p>4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.</p> <p>5. I/We also agree to the authorship of the article in the following sequence:-</p> <p>Authors' Names (in sequence) Signature of Authors<br>1. _____________________________________ _____________________________________<br>2. _____________________________________ _____________________________________<br>3. _____________________________________ _____________________________________<br>4. _____________________________________ _____________________________________<br>5. _____________________________________ _____________________________________<br>6. _____________________________________ _____________________________________<br>7. _____________________________________ _____________________________________<br>8. _____________________________________ _____________________________________</p> <p>Important</p> <p>(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.</p> <p>(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.</p> <p>(iii). If the authorship is contested at any stage, the article will be either returned or will not be<br>processed for publication till the issue is solved.</p> amin@adrpublications.in (Advanced Research Publications) Wed, 03 Jul 2024 06:57:09 +0000 OJS 3.2.1.1 http://blogs.law.harvard.edu/tech/rss 60 http://medicaljournalshouse.com/index.php/IntJ-PreventiveCardiology/article/view/1108 <p>Rheumatic heart disease (RHD) is a chronic heart condition that develops as a complication of untreated or inadequately treated streptococcal throat infections, particularly those caused by the Group A streptococcus bacteria. Although once a significant global health concern, improvements in healthcare and antibiotics have reduced its prevalence in many developed countries. However, RHD remains a serious issue in low-resource settings, affecting vulnerable populations, especially children and young adults.</p> <p>How to cite this article:<br />Kumar T, Singh M . Rheumatic Heart Disease. Int<br />J Preven Cardio 2023;3(2):1-4.</p> Mohit Singh, Tripti Kumar Copyright (c) 2023 Author's http://creativecommons.org/licenses/by-nc/4.0 http://medicaljournalshouse.com/index.php/IntJ-PreventiveCardiology/article/view/1108 Wed, 03 Jul 2024 00:00:00 +0000